141 related articles for article (PubMed ID: 8477565)
1. Perindopril as monotherapy in hypertension: a multicenter comparison of two dosing regimens. The Perindopril Study Group.
Chrysant SG; McDonald RH; Wright JT; Barden PL; Weiss RJ
Clin Pharmacol Ther; 1993 Apr; 53(4):479-84. PubMed ID: 8477565
[TBL] [Abstract][Full Text] [Related]
2. Antihypertensive efficacy and safety of perindopril in mild-to-moderate essential hypertension: results of a double-blind multicenter study versus atenolol.
Morgan TO; Louis WJ; MacDonald GJ; Conway EL; Bartholomeusz LC; Anderson AI; Cameron DP; Donnelly T; Frewin DB; Hooper MJ
Am J Med; 1992 Apr; 92(4B):73S-78S. PubMed ID: 1580284
[TBL] [Abstract][Full Text] [Related]
3. Clinical acceptability of ACE inhibitor therapy in mild to moderate hypertension, a comparison between perindopril and enalapril.
Alcocer L; Campos C; Bahena JH; Nacaud A; Parra Carillo J; Calvo C; Weber C; Lerebours G; Mickalonis L; Villahermosa MT
Cardiovasc Drugs Ther; 1995 Jun; 9(3):431-6. PubMed ID: 8527353
[TBL] [Abstract][Full Text] [Related]
4. A double blind comparison of perindopril and atenolol in essential hypertension.
Thurston H; Mimran A; Zanchetti A; Creytens G; Rorive G; Brown CL; Santoni JP
J Hum Hypertens; 1990 Oct; 4(5):547-52. PubMed ID: 2283644
[TBL] [Abstract][Full Text] [Related]
5. Once-daily trandolapril compared with the twice-daily formulation in the treatment of mild to moderate essential hypertension: assessment by conventional and ambulatory blood pressures.
Poirier L; Bourgeois J; Lacourcière Y
J Clin Pharmacol; 1993 Sep; 33(9):832-6. PubMed ID: 8227480
[TBL] [Abstract][Full Text] [Related]
6. A new trial of the efficacy, tolerability, and safety of angiotensin-converting enzyme inhibition in mild systemic hypertension with concomitant diseases and therapies. Perindopril Therapeutic Safety Study Group (PUTS).
Stumpe KO; Overlack A
Am J Cardiol; 1993 Jun; 71(17):32E-37E. PubMed ID: 8328365
[TBL] [Abstract][Full Text] [Related]
7. The effect of perindopril on blood pressure in humans on different sodium intakes.
Morgan T; Anderson A; Wilson D; Murphy J; Nowson C
J Cardiovasc Pharmacol; 1987; 10 Suppl 7():S116-8. PubMed ID: 2485043
[TBL] [Abstract][Full Text] [Related]
8. First-line treatment in hypertension. Role of perindopril.
Zanchetti A
Drugs; 1990; 39 Suppl 1():71-5. PubMed ID: 2407495
[TBL] [Abstract][Full Text] [Related]
9. The effect of perindopril and hydrochlorothiazide alone and in combination on blood pressure and on the renin-angiotensin system in hypertensive subjects.
Brown CL; Backhouse CI; Grippat JC; Santoni JP
Eur J Clin Pharmacol; 1990; 39(4):327-32. PubMed ID: 2076713
[TBL] [Abstract][Full Text] [Related]
10. Long-term acceptability of perindopril: European multicenter trial on 856 patients.
Degaute JP; Leeman M; Desche P
Am J Med; 1992 Apr; 92(4B):84S-90S. PubMed ID: 1580287
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of blood pressure control with once daily administration of enalapril and perindopril.
Anderson A; Morgan O; Morgan T
Am J Hypertens; 1994 Apr; 7(4 Pt 1):371-3. PubMed ID: 8031555
[TBL] [Abstract][Full Text] [Related]
12. Assessment of antihypertensive efficacy of perindopril: results of double-blind multicenter studies versus reference drugs.
Thurston H; Desche P
J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S45-9. PubMed ID: 1725202
[TBL] [Abstract][Full Text] [Related]
13. Short-term effects of withdrawing angiotensin converting enzyme inhibitor therapy on home self-measured blood pressure in hypertensive patients.
Vaur L; Bobrie G; Dutrey-Dupagne C; Dubroca I; Vaisse B; d'Yvoire MB; Elkik F; Chatellier G; Menard J
Am J Hypertens; 1998 Feb; 11(2):165-73. PubMed ID: 9524044
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and acceptability of perindopril in essential hypertension.
Sukonthasarn A; Ratanaprakarn R; Koanantakul B; Ngam-Ukos P
J Med Assoc Thai; 1994 Jun; 77(6):281-7. PubMed ID: 7869013
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of the dose-effect relationship of perindopril in the treatment of arterial hypertension].
Luccioni R; Frances Y; Gass R; Gilgenkrantz JM
Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():43-50. PubMed ID: 2505712
[TBL] [Abstract][Full Text] [Related]
16. A dose-response study of perindopril in hypertension: effects on blood pressure 6 and 24 h after dosing. Perindopril Multicentre Dose-Response Study Group.
Myers MG
Can J Cardiol; 1996 Nov; 12(11):1191-6. PubMed ID: 9191512
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of perindopril in the treatment of systemic hypertension.
Oparil S
Am J Cardiol; 2001 Oct; 88(7A):3i-12i. PubMed ID: 11591355
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the dose-effect relationship of a new ace inhibitor (perindopril) by an automatic blood pressure recorder.
Luccioni R; Frances Y; Gass R; Schwab C; Santoni JP; Perret L
Eur Heart J; 1988 Oct; 9(10):1131-6. PubMed ID: 3061819
[TBL] [Abstract][Full Text] [Related]
19. Value of angiotensin converting enzyme inhibitors in the elderly: the example of perindopril.
Forette F; McClaran J; Delesalle MC; Hervy MP; Bouchacourt P; Henry-Amar M; Santoni JP
Clin Exp Hypertens A; 1989; 11 Suppl 2():587-603. PubMed ID: 2691131
[TBL] [Abstract][Full Text] [Related]
20. Antihypertensive efficacy of the ACE-inhibitor perindopril in the elderly.
Leenen FH; Tanner J; McNally CF
J Hum Hypertens; 2000 May; 14(5):321-5. PubMed ID: 10822319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
